$54.00
-1.28-2.32%
At close: Jun 18, 5:00 PM EST
$54.10
0.100.19%
After Hours: Jun 18, 7:40 PM EST
Bristol-Myers Squibb Co Stock Guidance
BMYNYSE
Bristol-Myers Squibb (BMY) last issued guidance on April 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $6.05 - $6.35, compared to a consensus EPS estimate of $6.27. Bristol-Myers Squibb also guided revenue in the range of $46.00B - $47.50B for the period.
Compared to prior guidance, Bristol-Myers Squibb maintained its EPS outlook from a previous range of $6.05 - $6.35. On the revenue side, the company maintained its revenue forecast from a prior range of $46.00B - $47.50B.
Bristol-Myers Squibb has issued 16 guidance updates between July 27, 2022 and April 30, 2026. During this period, the company raised its outlook 5 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 30, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$6.05 - $6.35
Revenue Guidance Range
$46.00B - $47.50B
Bristol-Myers Squibb Guidance History
Review all historical guidance issued by Bristol-Myers Squibb, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Bristol-Myers Squibb (BMY)?
The most recent guidance for Bristol-Myers Squibb (BMY) was reported on April 30, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $6.05 to $6.35, compared to the estimated EPS of $6.27. Additionally, Bristol-Myers Squibb forecasted revenue between $46.00B and $47.50B for the period.
What EPS range did Bristol-Myers Squibb (BMY) guide for?
Bristol-Myers Squibb (BMY) guided EPS in the range of $6.05 to $6.35 for the fiscal year 2026. The consensus analyst EPS estimate is $6.27.
What revenue range did Bristol-Myers Squibb (BMY) guide for?
Bristol-Myers Squibb (BMY) guided revenue in the range of $46.00B to $47.50B for the fiscal year 2026.
Did Bristol-Myers Squibb (BMY) raise or lower guidance?
Bristol-Myers Squibb (BMY) maintained its EPS guidance from a prior range of $6.05 - $6.35 to $6.05 - $6.35 for the fiscal year 2026.
When did Bristol-Myers Squibb (BMY) last issue guidance?
Bristol-Myers Squibb (BMY) last issued guidance on April 30, 2026 for the fiscal year 2026.
